companies making glp 1 resistant foods Caution advised for GLP-1 labeling Taking GLP-1 obesity drugs? Here's
Description
Oncology dominates the hiring
GLP-1 users are spending less on indulgent snacks like chips and cookies, while buying more yogurt, fruit, and vegetables
Last week, Eli Lillys orforglipron has become the first oral, non-peptide GLP-1 receptor agonist to clear a Phase 3 trial, showing strong efficacy in reducing A1C (up to 1.6%) and body weight (up to 7.9%) in people with type 2 diabetes
Food intake was standardized, and blood samples were obtained every third hour
